MKGAF Stock UPDATES Merck Kgaa Dm 5 (MKGAF) 85.3000 08/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Merck Kgaa Dm 5 (MKGAF) 85.3000 $MKGAF

Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 15, 8:00AM CDT
Merck KGaA's (MKGAF) second-quarter 2014 earnings per American Depositary Receipt (ADR) came in at $1.52, down 1.8% from the year-ago quarter.

Roche Collaborates with Merck KGaA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 11, 5:30PM CDT
Roche's (RHHBY) Ventana Medical Systems announced that it has entered into an agreement with Germany-based Merck KGaA.

Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 4:20PM CDT
Merck KGaA (MKGAF) inked a deal with Mersana Therapeutics for the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancer.

Merck KGaA-Ono Pharma Deal Ends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 5:15PM CDT
Merck KGaA (MKGAF) has decided to terminate its license agreement with Ono Pharma related to the development of Ono Pharma's multiple sclerosis candidate, ceralifimod (ONO-4641).

Merck KGaA & MorphoSys Sign Deal, Immuno-Oncology in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 3:30PM CDT
Merck KGaA (MKGAF) and MorphoSys inked a deal to discover and develop therapeutic antibodies against undisclosed immune checkpoints.

Merck KGaA/Auxogyn's Eeva System Gets FDA Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 3:40PM CDT
Merck KGaA's (MKGAF) biopharma division, Merck Serono, announced that the FDA has granted clearance to Merck KGaA and partner Auxogyn's Early Embryo Viability Assessment (Eeva) System.

Merck KGaA Enrolls First Patient in Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 1:28PM CDT
Merck KGaA enrolled the first patient in a phase III study (ESPART) on Pergoveris

Merck KGaA Misses 2013 Earnings & Rev Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 9:30AM CST
Merck KGaA reported 2013 earnings per ADR of $11.70, up 19.2% year over year but below the Zacks Consensus Estimate of $11.99.

Avanir Reports Narrower Loss, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 11:40AM CST
Avanir Pharma reported first quarter fiscal 2014 net loss per share of 7 cents, narrower than the Zacks Consensus Estimate of a loss of 8 cents

Threshold Pharma Completes Enrolment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 3:45PM CST
Threshold Pharma completed enrolling patients in its phase III study, which is being conducted to evaluate TH-302 for the treatment of advanced soft tissue sarcoma.

Threshold Pharma's TH-302 in Melanoma Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 15, 12:00PM CDT
Threshold Pharmaceuticals recently initiated a phase II trial on its pipeline candidate, TH-302.

Update on Threshold Pharma's TH-302 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 08, 10:20PM CDT
Threshold Pharma announced an amendment in the protocol for its pivotal phase III study of TH-302

Sanofi's Lemtrada Gets CHMP Backing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 01, 11:40AM CDT
The Committee for Medicinal Products for Human Use recommended the approval of Lemtrada

Data on Merck KGaA's L-BLP25 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 22, 9:00PM CDT
Merck KGaA presented detailed results on its oncology candidate L-BLP25, from the phase III study, START.

Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 15, 10:24AM CDT
Merck KGaA reported first quarter 2013 earnings per American Depository Receipt (ADR) of $2.79, up 28.1% year over year.

Merck KGaA-CBRX Renew Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 11, 3:00PM CDT
Merck KGaA and Columbia Labs renewed a license and supply agreement for Crinone (progesterone gel), extending it for an additional five years

Sanofi Reports Lemtrada Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 27, 4:30PM CDT
Sanofi's subsidiary, Genzyme, announced interim data on Lemtrada.

Merck KGaA-BMY Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 21, 4:15PM CDT
Merck KGaA announced a deal with Bristol-Myers Squibb for the promotion of different formulations of Glucophage (metformin hydrochloride) in China.

Merck KGaA - Nordic Bioscience Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 20, 4:00PM CDT
Merck KGaA recently announced a strategic deal with Nordic Bioscience Clinical Development A/S for its pipeline candidate, sprifermin.

Threshold Cuts Loss, Misses Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 13, 9:00AM CDT
Threshold Pharmaceuticals Inc. reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 72

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
AI Deepfakes Met Their Match: IC-Corp's New Patent

Updated Category News Views 146

The Deepfake Fraud Reality Slap You know, in a world where you can't trust your own eyes on a video call, trust gets a bit sketchy, right? Imagine this scenario—an unsuspecting finance employee, surrounded by familiar faces and voices, only to wind up sending $25.6 million to fraudsters who weren't even real. A chilling real-world example from January 2024, courtesy of...

Continue Reading
Investor Scrutiny Intensifies Over M&A Deals at SGRY, RRC, EQT

Updated Category News Views 118

When Insiders Seem to Benefit More Ah, mergers and acquisitions—it's the oldest tango in the business world. But today, we've got some footwork that might trip up the small fry. Halper Sadeh LLC, the investor rights bulldogs, are sniffing around Surgery Partners, Range Resources, and EQT. Their quest? To uncover whether the big dogs are playing unfairly with...

Continue Reading
Mission Bancorp Hits Record Earnings, Extends Buyback

Updated Category News Views 60

Record-Breaking Quarter Amid Challenging Times When Mission Bancorp's earnings hit the tape today, the numbers were enough to catch anyone's eye—$9.2 million in net income for Q3 2026, a 6% increase from last year. That's not small potatoes, especially considering the economic fog we're navigating through. AJ Antongiovanni, holding the reins as CEO, credits the bank's...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 55

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
ADSQUIRE Dominates 2026 with Jaw-Dropping ROI and Award

Updated Category News Views 58

ADSQUIRE's Phenomenal ROI Grabs Industry Spotlight Just when you think the PPC world has seen it all, ADSQUIRE steps in and flips the script. With a jaw-dropping 8,000% return on investment (ROI) from a mere $4,000 ad spend in just one month, they've taken the PPC Agency of the Year title at the 2026 Search Engine Land Awards. For a Philadelphia-based agency focused on...

Continue Reading
Duke Energy's Battle Against Energy Vampires Heats Up

Updated Category News Views 248

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Continue Reading
Brennan Takes a Swing: Barrasso Endorsement in Hand

Updated Category News Views 44

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...

Continue Reading
ROKAE Hits 10,000 Delivery Mark for Robotic Arms

Updated Category News Views 167

ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...

Continue Reading
Revamp Preschool Questions for Richer Conversations

Updated Category News Views 81

Preschoolers, those tiny agents of chaos, come home with stories that you'd need a magnifying glass to find. Ask 'em "How was school?" and you're met with blank stares or a one-liner. Tami Nix of Archway Academy has been at this game for over 40 years, and she's got a trick or six up her sleeve. Ditch the Generic: Get Specific Yep, those generic questions are about as...

Continue Reading

Top 5 Most Recently Viewed Articles

Beneq Unveils Advanced Beneq Transform® XP for ALD Technology

Updated Category News Views 192

Beneq Introduces Next-Gen Beneq Transform® XP Beneq has recently announced the Beneq Transform® XP, a sophisticated second-generation atomic layer deposition (ALD) platform designed to address the evolving demands of Wide Bandgap (WBG) power and RF device manufacturing. This innovative system is poised to redefine atomic control and optimization in ALD processes....

Continue Reading
Capital Square Achieves Remarkable 152% Return for Investors

Updated Category News Views 115

Exceptional Returns Delivered by Capital Square In a notable transaction recently executed by Capital Square, investors have experienced a remarkable total return of 152%. The real estate investment firm, acknowledged for its prowess in tax-advantaged real estate investments, completed a successful UPREIT transaction involving the Mayton Transfer Lofts, a multifamily...

Continue Reading
Transforming Third-Party Risk Management in Cybersecurity

Updated Category News Views 243

Understanding the Challenges of Third-Party Risk Management In an era where cyber threats evolve rapidly, traditional approaches to vulnerability management are becoming increasingly inadequate. With a staggering increase of 38% year-over-year in published Common Vulnerabilities and Exposures (CVEs), organizations face significant challenges in navigating third-party risk...

Continue Reading
Newton Golf's Fast Motion Shaft: Revolutionizing Golf Performance

Updated Category News Views 355

Introducing the Newton Fast Motion Shaft NEWTON GOLF Company (NASDAQ: NWTG), a leader in innovative golf technology, has unveiled its latest creation—the Fast Motion shaft. This lightweight shaft is meticulously engineered for golfers seeking to maximize their driving distance and control without sacrificing performance. With a retail price of $325, the Newton Fast...

Continue Reading
LG Energy Solution Faces Challenges Amid Slowing EV Demand

Updated Category News Views 177

LG Energy Solution Reports Challenging Financial Results LG Energy Solution, a prominent player in the battery manufacturing sector, has recently announced a significant shift in its financial outlook. After three consecutive years of profitability, the company faced its first quarterly loss, raising concerns among investors and industry stakeholders alike. Decline in...

Continue Reading